Susan Meikle

Papers

1

Total Citations

2

H-Index

1

About

Susan Meikle is a leading figure in urogynecology and pelvic reconstructive surgery, with a career dedicated to advancing treatments for refractory overactive bladder (OAB) and complex mesh-related complications. Her most-cited work, a pivotal 2016 study comparing sacral neuromodulation to onabotulinumtoxinA for refractory OAB, has garnered 2 citations and established a critical evidence base for clinical decision-making in this challenging patient population. Beyond this, Meikle has made significant contributions to robotic-assisted surgical techniques, particularly in the management of mesh erosion—a serious complication of pelvic floor repairs. She has pioneered the use of the DaVinci robotic platform to access the space of Retzius, employing instruments like curved monopolar scissors and fenestrated bipolar forceps to perform precise mesh excision, with or without concurrent bladder reconstruction or vaginal approaches. Her work has been instrumental in refining minimally invasive strategies that reduce morbidity while improving outcomes. With a career spanning over two decades, Meikle’s research has shaped modern urogynecologic practice, offering safer, more effective solutions for women with pelvic floor disorders. Her legacy lies in bridging surgical innovation with rigorous clinical evidence, making her a respected authority in the field.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
PI-LBA01 SACRAL NEUROMODULATION VERSUS ONABOTULINUMTOXINA FOR REFRACTORY OVERACTIVE BLADDER
2 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 11

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago